Search Results - Pollio, Giuseppe
- Showing 1 - 7 results of 7
-
1
-
2
Safety, pharmacokinetics, pharmacogenomics and QT concentration-effect modelling of the SirT1 inhibitor selisistat in healthy volunteers by Westerberg, Goran, Chiesa, Joseph A, Andersen, Claus A, Diamanti, Daniela, Magnoni, Letizia, Pollio, Giuseppe, Darpo, Borje, Zhou, Meijian
Published 2015Text -
3
Estrogen Prevents the Lipopolysaccharide-Induced Inflammatory Response in Microglia by Vegeto, Elisabetta, Bonincontro, Cinzia, Pollio, Giuseppe, Sala, Angelo, Viappiani, Serena, Nardi, Francesca, Brusadelli, Alessia, Viviani, Barbara, Ciana, Paolo, Maggi, Adriana
Published 2001Text -
4
Magnetic resonance imaging of infarct-induced canonical wingless/integrated (Wnt)/β-catenin/T-cell factor pathway activation, in vivo by Matteucci, Marco, Casieri, Valentina, Gabisonia, Khatia, Aquaro, Giovanni Donato, Agostini, Silvia, Pollio, Giuseppe, Diamanti, Daniela, Rossi, Marco, Travagli, Massimiliano, Porcari, Valentina, Recchia, Fabio A., Lionetti, Vincenzo
Published 2016Text -
5
Development of an ELISA assay for the quantification of soluble huntingtin in human blood cells by Massai, Luisa, Petricca, Lara, Magnoni, Letizia, Rovetini, Luca, Haider, Salman, Andre, Ralph, Tabrizi, Sarah J, Süssmuth, Sigurd D, Landwehrmeyer, Bernhard G, Caricasole, Andrea, Pollio, Giuseppe, Bernocco, Simonetta
Published 2013Text -
6
A potent and selective Sirtuin 1 inhibitor alleviates pathology in multiple animal and cell models of Huntington's disease by Smith, Marianne R., Syed, Adeela, Lukacsovich, Tamas, Purcell, Judy, Barbaro, Brett A., Worthge, Shane A., Wei, Stephen R., Pollio, Giuseppe, Magnoni, Letizia, Scali, Carla, Massai, Luisa, Franceschini, Davide, Camarri, Michela, Gianfriddo, Marco, Diodato, Enrica, Thomas, Russell, Gokce, Ozgun, Tabrizi, S.J., Caricasole, Andrea, Landwehrmeyer, Bernard, Menalled, Liliana, Murphy, Carol, Ramboz, Sylvie, Luthi-Carter, Ruth, Westerberg, Goran, Marsh, J. Lawrence
Published 2014Text -
7
An exploratory double-blind, randomized clinical trial with selisistat, a SirT1 inhibitor, in patients with Huntington’s disease by Süssmuth, Sigurd D, Haider, Salman, Landwehrmeyer, G Bernhard, Farmer, Ruth, Frost, Chris, Tripepi, Giovanna, Andersen, Claus A, Di Bacco, Marco, Lamanna, Claudia, Diodato, Enrica, Massai, Luisa, Diamanti, Daniela, Mori, Elisa, Magnoni, Letizia, Dreyhaupt, Jens, Schiefele, Karin, Craufurd, David, Saft, Carsten, Rudzinska, Monika, Ryglewicz, Danuta, Orth, Michael, Brzozy, Sebastian, Baran, Anna, Pollio, Giuseppe, Andre, Ralph, Tabrizi, Sarah J, Darpo, Borje, Westerberg, Goran
Published 2015Text